Association between serotonin transporter gene polymorphism and chronic fatigue syndrome.
Narita, Masaaki, Nishigami, Naoko, Narita, Naoko et al. · Biochemical and biophysical research communications · 2003 · DOI
Quick Summary
This study looked at a specific gene that controls serotonin, a chemical messenger in the brain. Researchers compared the genetic versions of this gene in 78 ME/CFS patients and healthy controls. They found that ME/CFS patients were more likely to have a genetic variant that may reduce how much serotonin stays active in the brain, which could make people more vulnerable to developing ME/CFS.
Why It Matters
Understanding genetic factors that may contribute to ME/CFS susceptibility could help identify at-risk individuals and lead to better screening or prevention strategies. This study adds biological evidence to support the hypothesis that dysregulation of stress and mood-regulating systems plays a role in ME/CFS pathophysiology.
Observed Findings
Longer (L and XL) allelic variants of the 5-HTT gene promoter were significantly more frequent in CFS patients than controls
Allele-wise analysis confirmed the association between longer variants and CFS (p<0.05, Fisher's exact test)
The pattern suggests reduced transcriptional efficiency of longer variants may affect serotonin availability
Inferred Conclusions
The serotonin transporter gene polymorphism may contribute to individual susceptibility to ME/CFS
Disruption at the intersection of the hypothalamic-pituitary-adrenal axis and serotonergic system is implicated in CFS pathogenesis
Genetic variations affecting neurotransmitter regulation could underlie the biological basis of ME/CFS vulnerability
Remaining Questions
Do carriers of longer variants who do not develop ME/CFS have protective factors that prevent disease expression?
What is the actual functional impact of this genetic variant on serotonin transporter activity and extracellular serotonin levels in CFS patients versus controls?
How does this genetic finding interact with other genetic and environmental risk factors for ME/CFS?
What This Study Does Not Prove
This study shows an association between a genetic variant and ME/CFS but does not prove the variant causes the disease—many people with this genetic variant may never develop ME/CFS. The study does not demonstrate that this genetic difference actually produces the functional serotonin changes proposed, nor does it establish whether the genetic variant is a primary cause or a secondary effect of the illness.
Tags
Symptom:Fatigue
Biomarker:Gene Expression
Method Flag:Weak Case DefinitionSmall SampleExploratory Only